Inhibiting SphK2 reduces the production of sphingosine - 1 - phosphate (S1P), induces apoptosis of multiple myeloma (MM) cells and enhances the sensitivity of MM cells to proteasome inhibitors. The gene discussed is SPHK2; the disease is plasma cell myeloma.